Novartis AG
(NYSE : NVS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.74%145.000.7%$899.85m
PFEPfizer Inc. 0.76%37.360.9%$769.97m
MRKMerck & Co., Inc. 1.01%78.860.7%$631.89m
BMYBristol-Myers Squibb Co. 0.88%60.561.0%$627.99m
ABBVAbbVie, Inc. 2.13%84.661.9%$604.43m
LLYEli Lilly & Co. 0.18%141.561.1%$484.64m
AZNAstraZeneca Plc 0.50%51.831.2%$203.20m
NVSNovartis AG 0.37%84.450.2%$142.55m
GSKGlaxoSmithKline Plc -0.93%35.020.2%$137.60m
NVONovo Nordisk A/S -0.33%70.620.1%$69.71m
RPRXRoyalty Pharma Plc 0.51%39.200.2%$63.98m
RGENRepligen Corp. 2.41%175.917.1%$63.94m
SNYSanofi -0.25%49.050.2%$49.86m
AMAGAMAG Pharmaceuticals, Inc. 0.22%13.6622.1%$45.13m
OPKOPKO Health, Inc. 3.35%4.3211.2%$41.92m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.